| Our Products | |||||
| Sr.No. | Brand Name | Composition | |||
| 1 | Cefixime Tablets I.P. | Each Film Coated Tablets contains: | |||
| Cefixime | I.P. | 50 | mg | ||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 2 | Cefixime Tablets I.P. | Each Film Coated Tablets contains: | |||
| Cefixime | I.P. | 100 | mg | ||
| Eq. to Anhydrous Cefixime | Q.S. | ||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 3 | Cefixime Tablets I.P. | Each Film Coated Tablets contains: | |||
| Cefixime | I.P. | 200 | mg | ||
| Eq. to Anhydrous Cefixime | Q.S. | ||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 4 | Cefpodoxime Tablets I.P. | Each Film Coated Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 200 | mg | ||
| Eq. to Cefpodoxime | Q.S. | ||||
| Excipients:Colour : Approved Colour Used | |||||
| 5 | Cefixime Oral Suspension I.P. | Each 5ml of reconstituted suspension contains: | |||
| Cefixime | I.P. | 50 | mg | ||
| Eq. to Anhydrous Cefixime | Q.S. | ||||
| Excipients: Flavoured base : | Q.S. | ||||
| 6 | Cefixime Oral Suspension I.P. | Each 5ml of reconstituted suspension contains: | |||
| Cefixime | I.P. | 100 | mg | ||
| Eq. to Anhydrous Cefixime | Q.S. | ||||
| Excipients:Flavoured base : | Q.S. | ||||
| 7 | Cefpodoxime Oral Suspension I.P. | Each 5ml of reconstituted suspension contains: | |||
| Cefpodoxime Proxetil | I.P. | 50 | Mg | ||
| Eq. to Cefpodoxime | Q.S. | ||||
| Excipients:Flavoured base : | Q.S. | ||||
| 8 | Cefpodoxime Oral Suspension I.P. | Each 5ml of reconstituted suspension contains: | |||
| Cefpodoxime Proxetil | I.P. | 100 | Mg | ||
| Eq. to Cefpodoxime | Q.S. | ||||
| Excipients:Flavoured base : | Q.S. | ||||
| 9 | Cefuroxime Tablets I.P. | Each Film Coated Tablets contains: | |||
| Cefuroxime Axetil | I.P. | 250 | mg | ||
| Eq. to Anhydrous Cefuroxime | Q.S. | ||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 10 | Cefuroxime Tablets I.P. | Each Film Coated Tablets contains: | |||
| Cefuroxime Axetil | I.P. | 500 | mg | ||
| Eq. to Anhydrous Cefuroxime | Q.S. | ||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 11 | Amoxycillin & Potassium Clavulanate Tablets I.P. | Each Film Coated Tablets contains: | |||
| Amoxycillin Trihydrate | I.P. | 500 | mg | ||
| Eq. to Amoxycillin | I.P. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 12 | Amoxycillin Dispersible Tablets I.P. | Each Dispersible Tablets contains: | |||
| Amoxycillin Trihydrate | I.P. | 125 | mg | ||
| Eq.to Amoxycillin | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured Base: | |||||
| 13 | Amoxycillin Dispersible Tablets I.P. | Each Dispersible Tablets contains: | |||
| Amoxycillin Trihydrate | I.P. | 250 | mg | ||
| Eq.to Amoxycillin | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured Base: | |||||
| 14 | Ampicillin Dispersible Tablets I.P. | Each Dispersible Tablets contains: | |||
| Ampicillin Trihydrate | I.P. | 125 | mg | ||
| Eq. to Ampicillin | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured Base: | |||||
| 15 | Ampicillin Dispersible Tablets I.P. | Each Dispersible Tablets contains: | |||
| Ampicillin Trihydrate | I.P. | 250 | mg | ||
| Eq. to Ampicillin | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured Base: | |||||
| 16 | Amoxycillin Oral Suspension I.P. | Each 5ml of reconstituted suspension contains: | |||
| Amoxycillin Trihydrate | I.P. | 125 | mg | ||
| Eq. to Amoxycillin | |||||
| Excipients: | |||||
| Flavoured Base: | |||||
| 17 | Amoxycillin Oral Suspension I.P. | Each 5ml of reconstituted suspension contains: | |||
| Amoxycillin Trihydrate | I.P. | 250 | mg | ||
| Eq. to Amoxycillin | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured Base: | |||||
| 18 | Amoxycillin & Potassium Clavulanate Oral Suspension I.P. | Each 5ml of reconstituted suspension contains: | |||
| Amoxycillin Trihydrate | I.P. | 200 | mg | ||
| Eq. to Amoxycillin | I.P. | 28.5 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | Q.S. | ||||
| Excipients: | |||||
| Flavoured Base: | |||||
| 19 | Ampicillin Oral Suspension I.P. | Each 5ml of reconstituted suspension contains: | |||
| Ampicillin Trihydrate | I.P. | 125 | mg | ||
| Eq. to Ampicillin | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured Base: | |||||
| 20 | Amoxycillin & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Amoxycillin Trihydrate | I.P. | 250 | mg | ||
| Eq. to Amoxycillin | I.P. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 21 | Amoxycillin & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Amoxycillin Trihydrate | I.P. | 875 | mg | ||
| Eq. to Amoxycillin | I.P. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 22 | Amoxycillin & Potassium Clavulanate Dispersible Tablets | Each Dispersible Tablets contains: | |||
| Amoxycillin Trihydrate | I.P | 250 | mg | ||
| Eq. to Amoxycillin | I.P. | 150 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | Q.S. | ||||
| Excipients: | |||||
| Flavoured Base: | |||||
| Colour: Approved Colour Used | |||||
| 23 | Ampicillin & Dicloxacillin Tablets | Each Film Coated Tablets contains: | |||
| Ampicillin Trihydrate | I.P | 250 | mg | ||
| Eq. to Amoxycillin | I.P. | 250 | mg | ||
| Dicloxacillin Sodium | Q.S. | ||||
| Eq. to Dicloxacillin | |||||
| Excipients: | |||||
| Colour : Approved Colour Used | |||||
| 24 | Amoxycillin & Potassium Clavulanate Oral suspensions | Each 5 ml reconstituted suspension contains: | |||
| Amoxycillin Trihydrate | I.P. | 125 | mg | ||
| Eq. to Amoxycillin | I.P. | 31.25 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | Q.S. | ||||
| Excipients: | |||||
| Flavoured Base: | |||||
| Colour: Approved Colour Used | |||||
| 25 | Cefadroxil Tablets I.P. | Each Uncoated Tablets contains: | |||
| Cefadroxil Monohydrate | I.P. | 500 | mg | ||
| Eq. to Cefadroxil | Q.S. | ||||
| Excipients: | |||||
| Colour :Approved Colour Used | |||||
| 26 | Cefadroxil Tablets I.P. | Each Uncoated Tablets contains: | |||
| Cefadroxil Monohydrate | I.P. | 1000 | mg | ||
| Eq. to Cefadroxil | Q.S. | ||||
| Excipients: | |||||
| Colour :Approved Colour Used | |||||
| 27 | Cephalexin Tablets I.P. | Each Film coated Tablets contains: | |||
| Cephalexin | I.P. | 250 | mg | ||
| Eq. to Cephalexin Anhydrous | Q.S. | ||||
| Excipients: | |||||
| Colour :Approved Colour Used | |||||
| 28 | Cephalexin Tablets I.P. | Each Film coated Tablets contains: | |||
| Cephalexin | I.P. | 500 | mg | ||
| Eq. to Cephalexin Anhydrous | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured Base: | |||||
| Colour :Approved Colour Used | |||||
| 29 | Cephalexin Oral Suspension I.P. | Each 5 ml reconstituted suspension contains: | |||
| Cephalexin | I.P. | 125 | mg | ||
| Eq. to Cephalexin Anhydrous | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured Base: | |||||
| Colour :Approved Colour Used | |||||
| 30 | Cephalexin Oral Suspension I.P. | Each 5 ml reconstituted suspension contains: | |||
| Cephalexin | I.P. | 250 | mg | ||
| Eq. to Cephalexin Anhydrous | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured Base: | |||||
| Colour :Approved Colour Used | |||||
| 31 | Cefpodoxime Tablets I.P. | Each Film coated Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 50 | mg | ||
| Eq. to Cefpodoxime | Q.S. | ||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 32 | Cefpodoxime Tablets I.P. | Each Film coated Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 100 | mg | ||
| Eq. to Cefpodoxime | Q.S. | ||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 33 | Cefixime Oral Suspension I.P. | Each 5 ml of reconstituted suspension contains: | |||
| Cefixime | I.P. | 200 | mg | ||
| Eq.to Cefixime Anhydrous | Q.S. | ||||
| Excipients: | |||||
| Flavoured base: | |||||
| Colour: Approved Colour Used | |||||
| 34 | Cefixime Oral Suspension I.P. | Each 5 ml reconstituted suspension contains: | |||
| Cefixime | I.P. | 400 | mg | ||
| Eq. to Cefixime Anhydrous | Q.S. | ||||
| Flavoured base: | Q.S. | ||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 35 | Cefpodoxime Tablets I.P. | Each Film coated Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 200 | mg | ||
| Eq. to Cefpodoxime | Q.S. | ||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 36 | Cefuroxime Tablets I.P. | Each Film coated Tablets contains: | |||
| Cefuroxime Axetil | I.P. | 125 | mg | ||
| Eq. to Cefuroxime Anhydrous | Q.S. | ||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 37 | Cefaclor Oral Suspension I.P. | Each 5 ml reconstituted suspension contains: | |||
| Cefaclor Monohydrate | I.P. | 125 | mg | ||
| Eq. to Cefaclor | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured base: | |||||
| Colour: Approved Colour Used | |||||
| 38 | Cefaclor Oral Suspension I.P. | Each 5 ml reconstituted suspension contains: | |||
| Cefaclor Monohydrate | I.P. | 250 | mg | ||
| Eq. to Cefaclor | Q.S. | ||||
| Excipients: | Q.S. | ||||
| Flavoured base: | |||||
| Colour: Approved Colour Used | |||||
| 39 | Cefaclor Prolonged Release Tablets I.P. | Each Film coated Tablets contains: | |||
| Cefaclor Monohydrate | I.P. | 125 | mg | ||
| Eq. to Cefaclor | Q.S. | ||||
| Excipients | Q.S. | ||||
| Colour: Approved Colour Used | |||||
| 40 | Cefaclor Prolonged Release Tablets I.P. | Each Film coated Tablets contains: | |||
| Cefaclor Monohydrate | I.P. | 250 | mg | ||
| Eq. to Cefaclor | Q.S. | ||||
| Excipients | Q.S. | ||||
| Colour: Approved Colour Used | |||||
| 41 | Cefixime & Potassium Clavulanate Tablets | Each Film coated Tablets contains: | |||
| Cefixime | I.P. | 200 | mg | ||
| Eq. to Cefixime Anhydrous | Q.S. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 42 | Cefixime & Potassium Clavulanate Tablets | Each Film coated Tablets contains: | |||
| Cefixime | I.P. | 100 | mg | ||
| Eq. to Cefixime Anhydrous | Q.S. | 62.5 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 43 | Cefixime & Potassium Clavulanate Tablets | Each Film coated Tablets contains: | |||
| Cefixime | I.P. | 50 | mg | ||
| Eq. to Cefixime Anhydrous | Q.S. | 31.25 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 44 | Cefixime & Ofloxacin Tablets | Each Film coated Tablets contains: | |||
| Cefixime | I.P. | 100 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 100 | mg | ||
| Ofloxacin | Q.S. | ||||
| Excipients | |||||
| Colour: Approved Colour Used | |||||
| 45 | Cefixime & Ofloxacin Tablets | Each Film coated Tablets contains: | |||
| Cefixime | I.P. | 200 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 200 | mg | ||
| Ofloxacin | Q.S. | ||||
| Excipients | |||||
| Colour: Approved Colour Used | |||||
| 46 | Cefixime & Ofloxacin Sustained Release Tablets | Each Sustained Release Tablets contains: | |||
| Cefixime | I.P. | 200 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 200 | mg | ||
| Ofloxacin | Q.S. | ||||
| Excipients | |||||
| Colour: Approved Colour Used | |||||
| 47 | Cefixime & Ofloxacin Sustained Release Tablets | Each Sustained Release Tablets contains: | |||
| Cefixime | I.P. | 400 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 400 | mg | ||
| Ofloxacin | Q.S. | ||||
| Excipients | |||||
| Colour: Approved Colour Used | |||||
| 48 | Cefixime & Ofloxacin Dispersible Tablets | Each Uncoated Dispersible Tablets contains: | |||
| Cefixime | I.P. | 100 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 100 | mg | ||
| Ofloxacin | Q.S. | ||||
| Excipients | |||||
| Flavoured Base | |||||
| Colour: Approved Colour Used | |||||
| 49 | Cefixime & Ofloxacin Dispersible Tablets | Each Uncoated Dispersible Tablets contains: | |||
| Cefixime | I.P. | 200 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 200 | mg | ||
| Ofloxacin | Q.S. | ||||
| Excipients | |||||
| Flavoured Base | |||||
| Colour: Approved Colour Used | |||||
| 50 | Cefixime & Moxifloxacin Sustained Release Tablets | Each Sustained Release Tablets contains: | |||
| Cefixime (S.R.) | I.P. | 400 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 400 | mg | ||
| Moxifloxacin HCl (S.R.) | Q.S. | ||||
| Eq. to Anhydrous Moxifloxacin ( | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 51 | Cefpodoxime & Ofloxacin Dispersible Tablets | Each Uncoated Dispersible Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 100 | mg | ||
| Eq. to Cefpodoxime | I.P. | 100 | mg | ||
| Ofloxacin | Q.S. | ||||
| Excipients: | |||||
| Flavoured Base | |||||
| Colour: Approved Colour Used | |||||
| 52 | Cefpodoxime & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 200 | mg | ||
| Eq. to Cefpodoxime | I.P. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients | |||||
| Colour: Approved Colour Used | |||||
| 53 | Cefpodoxime & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 100 | mg | ||
| Eq. to Cefpodoxime | I.P. | 62.5 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients | |||||
| Colour: Approved Colour Used | |||||
| 54 | Cefpodoxime & Potassium Clavulanate Dispersible Tablets | Each Uncoated Dispersible Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 100 | mg | ||
| Eq. to Cefpodoxime | I.P. | 62.5 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Flavoured Base: | |||||
| Colour: Approved Colour Used | |||||
| 55 | Cefpodoxime & Potassium Clavulanate Oral Suspension | Each 5 ml of reconstituted suspension contains: | |||
| Cefpodoxime Proxetil | I.P. | 100 | mg | ||
| Eq. to Cefpodoxime | I.P. | 62.5 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq.to Clavulanic Acid | |||||
| Excipients: | |||||
| Flavoured Base: | |||||
| Colour: Approved Colour Used | |||||
| 56 | Cefpodoxime & Potassium Clavulanate Oral Suspension | Each 5 ml of reconstituted suspension contains: | |||
| Cefpodoxime Proxetil | I.P. | 50 | mg | ||
| Eq. to Cefpodoxime | I.P. | 31.25 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Flavoured Base: | |||||
| Colour: Approved Colour Used | |||||
| 57 | Cefpodoxime & Potassium Clavulanate Dispersible Tablets | Each Uncoated Dispersible Tablets contains: | |||
| Cefpodoxime Proxetil | I.P. | 50 | mg | ||
| Eq. to Cefpodoxime | I.P. | 31.25 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Flavoured Base: | |||||
| Colour: Approved Colour Used | |||||
| 58 | Cefuroxime & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Cefuroxime Axetil | I.P. | 250 | mg | ||
| Eq.to Anhydrous Anhydrous | I.P. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 59 | Cefuroxime & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Cefuroxime Axetil | I.P. | 125 | mg | ||
| Eq. to Cefuroxime Anhydrous | I.P. | 62.5 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 60 | Cefuroxime & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Cefuroxime Axetil | I.P. | 250 | mg | ||
| Eq. to Cefuroxime Anhydrous | I.P. | 62.5 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 61 | Cefuroxime & Potassium Clavulanate Tablets | Each Film Coated Tablets contains: | |||
| Cefuroxime Axetil | I.P. | 500 | mg | ||
| Eq. to Cefuroxime Anhydrous | I.P. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Colour: Approved Colour Used | |||||
| 62 | Cefixime & Potassium Clavulanate Oral Suspension | Each 5 ml of reconstituted suspension contains: | |||
| Cefixime | I.P. | 100 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 62.5 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Flavoured Base: | |||||
| Colour: Approved Colour Used | |||||
| 63 | Cefixime & Potassium Clavulanate Oral Suspension | Each 5 ml of reconstituted suspension contains: | |||
| Cefixime | I.P. | 50 | mg | ||
| Eq. to Cefixime Anhydrous | I.P. | 31.25 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Flavoured Base: | |||||
| Colour: Approved Colour Used | |||||
| 64 | Cefuroxime & Potassium Clavulanate Oral Suspension | Each 5 ml of reconstituted suspension contains: | |||
| Cefuroxime Axetil | I.P. | 250 | mg | ||
| Eq. to Cefuroxime Anhydrous | I.P. | 125 | mg | ||
| Potassium Clavulanate Diluted | Q.S. | ||||
| Eq. to Clavulanic Acid | |||||
| Excipients: | |||||
| Flavoured Base: | |||||
| Colour: Approved Colour Used | |||||